Analyzing collaboration networks and developmental patterns of nano-enabled drug delivery (NEDD) for brain cancer

The rapid development of new and emerging science & technologies (NESTs) brings unprecedented challenges, but also opportunities. In this paper, we use bibliometric and social network analyses, at country, institution, and individual levels, to explore the patterns of scientific networking for a key nano area – nano-enabled drug delivery (NEDD). NEDD has successfully been used clinically to modulate drug release and to target particular diseased tissues. The data for this research come from a global compilation of research publication information on NEDD directed at brain cancer. We derive a family of indicators that address multiple facets of research collaboration and knowledge transfer patterns. Results show that: (1) international cooperation is increasing, but networking characteristics change over time; (2) highly productive institutions also lead in influence, as measured by citation to their work, with American institutes leading; (3) research collaboration is dominated by local relationships, with interesting information available from authorship patterns that go well beyond journal impact factors. Results offer useful technical intelligence to help researchers identify potential collaborators and to help inform R&D management and science & innovation policy for such nanotechnologies.

[1]  Alan L. Porter,et al.  Analyzing patent topical information to identify technology pathways and potential opportunities , 2014, Scientometrics.

[2]  Mark E. J. Newman A measure of betweenness centrality based on random walks , 2005, Soc. Networks.

[3]  M. Hochberg,et al.  Author Sequence and Credit for Contributions in Multiauthored Publications , 2007, PLoS biology.

[4]  N. Islam,et al.  Collaborative networks and technology clusters - the case of nanowire , 2014 .

[5]  Wolfgang Glänzel,et al.  Modelling and measuring multilateral co-authorship in international scientific collaboration. Part II. A comparative study on the extent and change of international scientific collaboration links , 2006, Scientometrics.

[6]  魏屹东,et al.  Scientometrics , 2018, Encyclopedia of Big Data.

[7]  J. Pedraz,et al.  Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research , 2012, Clinical and Translational Oncology.

[8]  Seeram Ramakrishna,et al.  Drug delivery vehicles on a nano-engineering perspective. , 2014, Materials science & engineering. C, Materials for biological applications.

[9]  Hongyuan Wang,et al.  International Collaboration Activity Index: Case study of dye-sensitized solar cells , 2014, J. Informetrics.

[10]  Xiaoli Wei,et al.  Brain tumor-targeted drug delivery strategies , 2014, Acta pharmaceutica Sinica. B.

[11]  Thomas R. Scott,et al.  QUAD system offers fair shares to all authors , 2003, Nature.

[12]  Stephen P. Borgatti,et al.  Centrality and network flow , 2005, Soc. Networks.

[13]  Rongrong Li,et al.  Collaboration network and pattern analysis: case study of dye-sensitized solar cells , 2013, Scientometrics.

[14]  Tejraj M Aminabhavi,et al.  Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Ying Guo,et al.  Nano-enabled drug delivery: a research profile. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[16]  Gorka Orive,et al.  Drug delivery in biotechnology: present and future. , 2003, Current opinion in biotechnology.

[17]  Andrew McCaskie,et al.  Nanomedicine , 2005, BMJ.

[18]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[19]  A. R. Kulkarni,et al.  Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review , 2011, Expert opinion on drug delivery.

[20]  Nelson Durán,et al.  New aspects of nanopharmaceutical delivery systems. , 2008, Journal of nanoscience and nanotechnology.

[21]  Robert Langer,et al.  Nanoparticle delivery of cancer drugs. , 2012, Annual review of medicine.

[22]  Alan L. Porter,et al.  Forecasting Innovation Pathways (FIP) for new and emerging science and technologies , 2013 .